267 related articles for article (PubMed ID: 17059518)
1. Octreotide therapy in dumping syndrome: Analysis of long-term results.
Didden P; Penning C; Masclee AA
Aliment Pharmacol Ther; 2006 Nov; 24(9):1367-75. PubMed ID: 17059518
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome.
Penning C; Vecht J; Masclee AA
Aliment Pharmacol Ther; 2005 Nov; 22(10):963-9. PubMed ID: 16268971
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping.
Arts J; Caenepeel P; Bisschops R; Dewulf D; Holvoet L; Piessevaux H; Bourgeois S; Sifrim D; Janssens J; Tack J
Clin Gastroenterol Hepatol; 2009 Apr; 7(4):432-7. PubMed ID: 19264574
[TBL] [Abstract][Full Text] [Related]
4. Treatment of small intestinal disease in systemic sclerosis with octreotide: a prospective study in seven patients.
Nikou GC; Toumpanakis C; Katsiari C; Charalambopoulos D; Sfikakis PP
J Clin Rheumatol; 2007 Jun; 13(3):119-23. PubMed ID: 17551375
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of octreotide-therapy in severe dumping syndrome.
Vecht J; Lamers CB; Masclee AA
Clin Endocrinol (Oxf); 1999 Nov; 51(5):619-24. PubMed ID: 10594523
[TBL] [Abstract][Full Text] [Related]
6. Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia.
Scaglione G; Pietrini L; Russo F; Franco MR; Sorrentini I
Aliment Pharmacol Ther; 2007 Sep; 26(6):935-42. PubMed ID: 17767478
[TBL] [Abstract][Full Text] [Related]
7. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
[TBL] [Abstract][Full Text] [Related]
8. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.
Mohnike K; Blankenstein O; Pfuetzner A; Pötzsch S; Schober E; Steiner S; Hardy OT; Grimberg A; van Waarde WM
Horm Res; 2008; 70(1):59-64. PubMed ID: 18493152
[TBL] [Abstract][Full Text] [Related]
9. The dumping syndrome. Current insights into pathophysiology, diagnosis and treatment.
Vecht J; Masclee AA; Lamers CB
Scand J Gastroenterol Suppl; 1997; 223():21-7. PubMed ID: 9200302
[TBL] [Abstract][Full Text] [Related]
10. An open trial of octreotide long-acting release in the management of short bowel syndrome.
Nehra V; Camilleri M; Burton D; Oenning L; Kelly DG
Am J Gastroenterol; 2001 May; 96(5):1494-8. PubMed ID: 11374688
[TBL] [Abstract][Full Text] [Related]
11. Global improvement of systemic scleroderma under long-term administration of octreotide.
Descamps V; Duval X; Crickx B; Bouscarat F; Coffin B; Belaich S
Eur J Dermatol; 1999 Sep; 9(6):446-8. PubMed ID: 10491499
[TBL] [Abstract][Full Text] [Related]
12. Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer.
Matulonis UA; Seiden MV; Roche M; Krasner C; Fuller AF; Atkinson T; Kornblith A; Penson R
J Pain Symptom Manage; 2005 Dec; 30(6):563-9. PubMed ID: 16376743
[TBL] [Abstract][Full Text] [Related]
13. [A prolonged-action somatostatin analog and carcinoid syndrome].
Chayvialle JA
Bull Acad Natl Med; 1989 May; 173(5):643-50; discussion 650-1. PubMed ID: 2478266
[TBL] [Abstract][Full Text] [Related]
14. Octreotide for recurrent intestinal variceal bleeding in patients without portal hypertension.
Dray X; Vahedi K; Odinot JM; Marteau P
Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):836-9. PubMed ID: 19381096
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome.
Hasler WL; Soudah HC; Owyang C
J Pharmacol Exp Ther; 1996 Jun; 277(3):1359-65. PubMed ID: 8667198
[TBL] [Abstract][Full Text] [Related]
16. Yellow nail syndrome: treatment with octreotide.
Hillerdal G
Clin Respir J; 2007 Dec; 1(2):120-1. PubMed ID: 20298292
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term treatment with octreotide on rectal sensitivity in patients with non-constipated irritable bowel syndrome.
Klooker TK; Kuiken SD; Lei A; Boeckxstaens GE
Aliment Pharmacol Ther; 2007 Aug; 26(4):605-15. PubMed ID: 17661764
[TBL] [Abstract][Full Text] [Related]
18. Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.
Mystakidou K; Katsouda E; Tsilika E; Smyrniotis V; Vassiliou I; Tsiatas M; Vlahos L
Anticancer Res; 2006; 26(3B):2325-8. PubMed ID: 16821610
[TBL] [Abstract][Full Text] [Related]
19. Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases.
Nardone G; Compare D; Scarpignato C; Rocco A
Dig Liver Dis; 2014 Aug; 46(8):688-94. PubMed ID: 24893688
[TBL] [Abstract][Full Text] [Related]
20. [Postgastrectomy dumping treated with octreotide (Sandostatin)].
Møller TD; Carlsen CU
Ugeskr Laeger; 1993 Jun; 155(23):1805-6. PubMed ID: 8317033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
